The COMPUS Observer

The COMPUS Observer is a collection of information from various organizations involved with reviewing best practices in medication prescribing and use, including the Canadian Agency for Drugs and Technologies in Health (CADTH), Australia's National Prescribing Service (NPS), the National Institute for Health and Clinical Excellence (NICE - UK), and Oregon's Drug Effectiveness Review Project (DERP). The information goes back to 2004 and is updated on a regular basis.

TEXT files contain text

PowerPoint files contain slides that can be incorporated into any presentation

Presentation files contain presentations in pdf form and cannot be inserted into individual presentations

The COMPUS Observer is an annual subscription service. The information is divided into six sections and files can be easily downloaded by clicking on the links in the Table of Contents. To order, click on "Add to basket" below or contact us at info@wyatthealth.com or 1-905-257-5670.

If you are already a subscriber, please log in and click on "more information" to access the files. Please note that subscribers need to register and create a user name and password.

$ 2,500.00

Section 1000 - Canadian Agency for Drugs and Technologies in Health (CADTH)

CADTH is the home of Canadian Optimal Medication Prescribing and Use Service ( COMPUS), the Common Drug Review ( CDR), and also does Health Technology Assessments ( HTA). CADTH is focused on providing timely, relevant and rigorously derived evidence-based information to decision makers and support for the decision-making processes.

Number	Title	Format	Date
1001	About CADTH	PowerPoint	2006-12-08
1051	CADTH Affiliations	PowerPoint	2006-12-11
1101	CCOHTA Annual Report 1999-2000	TEXT	2000-03-31
1102	CCOHTA Annual Report 2000-2001	TEXT	2001-03-31
1103	CCOHTA Annual Report 2001-2002	TEXT	2002-03-31
1104	CCOHTA Annual Report 2002-2003	TEXT	2003-03-31
1105	CCOHTA Annual Report 2003-2004	TEXT	2004-03-31
1106	CCOHTA Annual Report 2004-2005	TEXT	2005-03-31
1201	CCOHTA Business Plan 2003-2004	TEXT	March 2003
1202	CCOHTA Health Technology Strategy 1.0	TEXT	June 2004
1203	CCOHTA Strategic Plan 2004-2008	TEXT	2004-06-10
1204	CCOHTA Health Technology Strategy – Implementation Strategy	TEXT	April 2005
1205	CCOHTA Business Plan 2005-2006	TEXT	2005-05-12
1206	CCOHTA Strategic Business Plan 2006-2011	TEXT	2005-10-07
1207	CADTH Annual Business Plan 2006-2007	TEXT	2006-04-05

Section 2000 - Canadian Optimal Medication Prescribing & Utilization Service (COMPUS)

In partnership with the Federal/Provincial/Territorial (F/P/T) Health Ministries, the goal of COMPUS is to identify and promote evidence-based best practices in drug prescribing and use among health care providers and consumers.

Number	Title	Format	Date
2001	About COMPUS	PowerPoint	2007-01-11
2101	COMPUS Launch Presentation - Barb Shea	Presentation	Fall 2004
2102	COMPUS Launch Presentation – Barbara Wells	Presentation	Fall 2004
2103	Overview of Stakeholder Meetings - Fall 2004	TEXT	2005-04-20
2104	COMPUS Report of Fall 2004 Stakeholder Sessions (Full)	TEXT	2005-04-20
2105	COMPUS Report of Fall 2004 Stakeholder Sessions (Executive Summary)	TEXT	2005-04-20
2106	COMPUS – Agenda for Consultation Meeting – June 10, 2005	TEXT	2005-06-03
2108	COMPUS Consultation Presentation – June 10, 2005 - B Wells (with notes)	Presentation	2005-07-04
2109	COMPUS Consultation Presentation – June 10, 2005 - G Bak (with notes)	Presentation	2005-07-04
2112	COMPUS – Stakeholder Consultation Session – June 10, 2005 (Summary Report)	TEXT	2005-09-27
2113	COMPUS – Request for Comment on COMPUS Procedure	TEXT	2005-11-15
2114	COMPUS - Evaluation Tools - Request for Comment	TEXT	2005-11-29
2115	COMPUS - Evaluation Tools - Final	TEXT	2005-12-20
2116	COMPUS – Procedure – Final	TEXT	2006-01-13

Section 3000 - Medication Prescribing and Use Projects (MPUP)

Individualized prescibing and appropriate use of medications can lead to better outcomes. It has been well documented that not all patients take their medications as directed. This occurs for a variety of reasons. While the goals of each program noted below are different, they have all achieved a degree of success in influencing medication prescribing and/or use. The programs illustrate ways in which behaviour can be influenced and can serve as a guide for the development of future programs by either the public or private sector. Thus far, the MPUP collection contains data on over 30 Canadian projects.

Number	Title	Format	Date
3001	What is the Medication Prescribing Utilization Project (MPUP) Collection	PowerPoint	2005-08-04
3101	NS - Diabetes Case Management	TEXT	2005-04-06
3102	NS - Physician Profiling - Corticosteroids	TEXT	2005-04-15
3103	Canada - e-Therapeutics Management Tools	TEXT	2005-04-18
3104	SK - Rx Files - Academic Detailing	TEXT	2005-04-21
3105	Canada - Canadian Hypertension Education Program	TEXT	2005-04-21
3106	AB - Academic Detailing Program	TEXT	2005-04-21
3107	NS - Drug Evaluation Alliance of Nova Scotia - DEANS	TEXT	2005-09-20
3108	MB - Prescription Information Services of Manitoba - PrISM	TEXT	2005-09-28
3109	BC - Community Drug Utilization Program - BC-CDUP	TEXT	2005-09-30
3110	ON - Integrating Family Medicine and Pharmacy to Advance Primary Care Therapeutics - IMPACT	TEXT	2005-10-05
3111	BC - FHA Community Based Medication Management Program	TEXT	2005-10-18
3112	NS - Dalhousie CME Academic Detailing - 2001	TEXT	2005-10-25
3113	AB - Improving Blood Pressure Management in Patients with Diabetes	TEXT	2005-10-31
3114	AB - The OsteoPharm Study	TEXT	2005-11-23
3115	BC - BC Nurse-Line Chronic Disease Management Project	TEXT	2005-11-28
3116	BC - Community Pharmacy Asthma Study	TEXT	2005-12-12
3117	SK - Saskatchewan Drug Information Service	TEXT	2005-12-14
3118	SK - Strict Control of Blood Glucose in Critically Ill Patients	TEXT	2006-01-17
3119	BC - Burnaby Delirium Assessment and Treatment Protocol	TEXT	2006-01-20
3120	ON – Trial of Education and Concordance in Heart Failure (TEACH)	TEXT	2006-02-08
3121	MB - Cardiovascular Risk Intervention by Manitoba Pharmacists (CRIMP)	TEXT	2006-02-08

Section 4000 - Australia - National Prescribing Service (NPS)

The National Prescribing Service (NPS) is an independent Australian organization supporting Quality Use of Medicines ( QUM). Their focus is to ensure quality use of medicines which are chosen with attention to safety and effectiveness. Some of the key NPS reviews focus on dyslipidemias, hypertension, Type II diabetes, etc.

Number	Title	Format	Date
4001	What is the National Prescribing Service (NPS)	PowerPoint	2005-05-02
4002	What is the National Prescribing Service (NPS)	TEXT	2005-08-09
4003	What is Quality Use of Medicines (QUM)	TEXT	2005-08-09

Section 5000 - United Kingdom - National Institute for Health and Clinical Excellence (NICE)

The National Institute for Clinical Excellence ( NICE) serves both England and Wales and works on behalf of the National Health Service. NICE provides patients, health professionals and the public with treatment recommendations using “best practice” standards. NICE guidance deals with subjects ranging from management of Type II diabetes to Hypertension in adults and many other subjects.

Number	Title	Format	Date
5001	What is NICE	PowerPoint	2007-01-25

Section 6000 - USA - Oregon - Drug Effectiveness Review Project (DERP)

The Drug Effectiveness Review Project ( DERP) was founded and is located at Oregon Health and ScienceUniversity. The members of DERP collaborate on the best available evidence with respect to comparing the effectiveness and safety of drugs in the same class. Some of the drug classes chosen for review are HMG Co-A Reductase Inhibitors, Proton Pump Inhibitors, and Angiotensin Receptor Blockers.

Number	Title	Format	Date
6001	What is the Drug Effectiveness Review Project (DERP)	PowerPoint	2007-01-16
6101	Kaizer Review of DERP	TEXT	2006-03-17